How Do GLP-1 Receptor Agonists Help With Weight Loss? (October 2026)

01 · The short answer

How GLP-1 receptor agonists help with weight loss

They help by changing appetite, not by melting fat directly. Your gut releases hormones after meals that tell the body it has eaten. GLP-1 receptor agonists activate the same gut-hormone receptors. Tirzepatide is described like this: together, GIP and GLP-1 receptor activity help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That is the honest mechanism: the medicine makes eating less easier, and the diet change produces the weight loss. If you want the longer technical explanation, our guide to how these medicines work goes further, and our page on the GLP-1 receptor as a drug target covers the receptor biology.

02 · Is this relevant to you?

Is this relevant to you, and what should you do next?

It is relevant if you are an adult with a weight-management need that diet and activity alone have not met. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.¹

The NHS route exists but is phased. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first.⁴⁶ Many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you are ready to look at private treatment, the Mounjaro pen starts at a standard price of £169.99 per month for the 2.5mg starter pen, and a new customer's first 2.5mg pen costs £129.99 with code FIRST40. Every later order is £25 off the standard price. Our GLP-1 cost guide compares options, and our weight loss clinic page explains the consultation. The consultation is free and the price shown is the price paid.

03 · Appetite and fullness

Appetite and fullness: what changes day to day

The most noticeable change is in hunger. For tirzepatide, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

Think of it as turning the volume down on a constant background signal. Many people describe, in general terms, that the urge to snack or finish a large plate eases.

This matters for expectations. A person who understands the medicine as an appetite regulator tends to plan better: building meals around protein and vegetables, stopping when full and noticing the new signals. Someone who expects the pen to work whatever they eat will be disappointed. The medicine is used alongside a reduced-calorie diet and increased physical activity, not instead of them.

Appetite regulation is also why dose steps matter. Treatment starts at the 2.5mg strength and increases through the pen strengths, and the prescribing team reviews how you are responding before each step.

What about products sold as ways to "boost" your own GLP-1? Our page on whether GLP-1 boosters help with weight loss looks at that marketing. In short, a supplement is not a licensed medicine and does not act in the same way as a prescribed receptor agonist.

The practical takeaway: expect the medicine to make healthy eating easier, and expect to still do the eating. People who pair treatment with sensible food choices and regular activity give the medicine the best chance of working as intended. Tell your prescriber at review if appetite feels too suppressed or not changed at all; both are useful information for dosing decisions.

04 · Slower stomach emptying

Slower stomach emptying and why it matters

GLP-1 medicines slow how quickly the stomach empties.¹ Food stays in the stomach for longer, so the feeling of satisfaction after a meal lasts longer and the gap before you feel hungry again stretches out.

It also explains some things people notice. Because digestion is slower, large or very rich meals can feel uncomfortable. Eating smaller portions and stopping when you feel satisfied tends to suit the medicine better than eating to a habit.

Slower stomach emptying matters for medicines taken by mouth. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you use an oral contraceptive, raise this with the prescriber during your consultation so you can agree a plan.⁷

Similarly, if you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. That is a conversation for your prescriber or diabetes team, not something to decide alone. It is not a reason the medicines cannot be used together; it is a reason to plan the doses.

Why does this slow-down not simply mean "you eat less and that is it"? Because the effect is part of a wider hormone signal. The same receptor activity that slows emptying also helps regulate appetite and improves the way the body responds to insulin, so these effects work together rather than as separate tricks.

For most readers the useful message is simple. Slower emptying is a feature, not a flaw, and it is a main reason the medicine supports a reduced-calorie diet. If anything about digestion worries you, speak to the prescribing team, who provide ongoing monthly reviews and side-effect support for people we treat.

05 · Insulin response

The insulin response and the type 2 diabetes licence

These medicines also improve the way the body responds to insulin.¹ In the UK it is licensed for weight management in adults and for type 2 diabetes.¹

For someone using the medicine for weight management, the insulin effect is part of the overall picture rather than the headline. The headline is appetite and fullness.

NICE has separate guidance for the two uses. The tirzepatide guidance for diabetes sits apart from the guidance on overweight and obesity, so NHS eligibility depends on which condition is being treated.⁴⁸ If you have diabetes, your diabetes team is the right first contact, because your other medicines may need review.

The same applies if you take other glucose-lowering treatment. Doses may need adjusting because of low blood sugar risk, and the prescriber will ask about all your medicines during the consultation. Always list everything you take, including over-the-counter products.

If you are weighing GLP-1 medicines against other options, bear in mind that the insulin-related action is one reason prescribers ask detailed health questions up front. The free consultation we offer is a short health questionnaire, followed by review from a GPhC-registered prescriber, and unsuitable orders are refunded automatically.

06 · What the trials show

What the trial evidence shows

SURMOUNT-1 is the main tirzepatide weight-loss trial. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Trial averages do not predict your own result.

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

Note what the comparison group tells you. The lifestyle-only group also lost some weight, which shows that diet and activity matter in their own right. The medicine added to that effort. It did not replace it.

SURMOUNT-5 is the first large head-to-head trial of tirzepatide and semaglutide for weight loss.¹⁵ Semaglutide's own trial, STEP 1, stands on its own evidence.⁹

For a rough sense of scale only, a worked example: for someone starting at 100 kg, 20.9% is about 21 kg. That is a trial average at the highest strength over 72 weeks, not a forecast. Many people will lose less, some more.

Your own outcome depends on dose, your health and your habits, alongside lifestyle change. Our page on whether Mounjaro can help with weight loss in the UK covers expectations in more detail.

07 · Mounjaro versus single-action

Dual action versus single-action GLP-1 medicines

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹

That is a statement about mechanism, not a verdict on which is better for you. Both are effective licensed treatments. Wegovy comes as pens of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, stepping up after at least four weeks and reaching the 2.4mg maintenance dose from week 17.¹⁸ Mounjaro comes as a pre-filled multi-dose KwikPen in strengths of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

You can read about the Wegovy option on our Wegovy pen page. Whichever you choose, treatment is prescription-only and reviewed by a GPhC-registered prescriber.

How is liraglutide different? Liraglutide (Saxenda, and products such as Erly) is supplied at a concentration of 6mg per millilitre, and it is a daily injection, unlike once-weekly Mounjaro and Wegovy.

Why mention Ozempic? Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. Wegovy (semaglutide 2.4mg) is licensed for weight management.

If you want the full list of medicines in this class, see our list of GLP-1 receptor agonists. For the class in general, the guide to the GLP-1 receptor agonist class gives a reference overview.

The decision usually rests on practical factors: dosing schedule, how you responded to previous treatment, tolerability, cost and your prescriber's advice.

08 · Safety and who should not

Downsides, long-term effects and who should not take it

Every medicine has downsides, and GLP-1 medicines are no exception. Most side effects are digestive: the most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. They are most likely when starting or moving up a dose and for most people ease within days to a few weeks.¹¹³ Read the patient leaflet before you start, and if you notice anything new, speak to your prescriber and report it through the Yellow Card scheme.¹⁹

Our prescribing team provides ongoing monthly reviews, dose-titration and follow-up assessments, and repeat orders re-check suitability. There is no auto-shipping.

Regulators monitor these medicines. The EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link between GLP-1 medicines and suicidal thoughts, and the MHRA keeps this under continuous review.¹⁷ If you have concerns about mood, tell your prescriber.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Who should not take Mounjaro? You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.

Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. Switch to a non-oral method, or add a barrier method (such as condoms), for 4 weeks after starting and for 4 weeks after each dose increase. If you use insulin or sulfonylureas, doses may need adjusting because of low blood sugar risk.⁷

What should you avoid? Avoid buying from anyone offering to supply without a consultation or prescription; counterfeit medicines are a genuine risk, and the MHRA publishes alerts.⁷ Mounjaro we supply is genuine KwikPens through official LillyDirect supply from Eli Lilly's UK distribution.

If you are struggling with tolerability, call the team; the support line runs Monday to Friday, 9am to 5pm.

09 · Ordering and supply

Private treatment: how ordering works

If the medicine suits you, ordering through us follows a simple route. We are a GPhC-registered UK online pharmacy with free next-day tracked delivery in temperature-controlled packaging, and over 100,000 customers have been supported on their weight loss journey.

Step one is a free online consultation: a short health questionnaire, no charge and no obligation. Step two is review by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Step three is dispensing by our registered pharmacy, with same-day dispatch when ordered by 3pm, and delivery is free next-day tracked, with Saturday delivery at £14.99.

On cost, the standard monthly prices run from £169.99 at 2.5mg to £329.99 at 15mg, and all six doses are in stock. A new customer's first order is £40 off at any dose with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices; a new customer's first order is £40 less and every later order £25 less. Prices checked 10 October 2026.

Payment is by Visa or Mastercard, Klarna and pay-monthly options, with no subscriptions. Needles, a sharps bin and injection guidance are included with every order, and the free GLPTrackr companion app helps you track your journey.

Storage matters once the pen arrives. Store pens in the fridge at 2–8°C until first use, and they keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or frozen.¹³

If you ever stop treatment, tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹

For the NHS comparison, remember that Mounjaro is available on the NHS, but access is being phased in over several years, so a private route suits some people who want to start sooner.⁴⁶

10 · Natural alternatives

Natural GLP-1 claims and the "poor man's Ozempic"

The phrase "poor man's Ozempic" is marketing for low-cost supplements, most often berberine. It is not a medicine in the same sense, and it is not a licensed GLP-1 receptor agonist. Supplements are available cheaply without assessment and carry no clinical oversight, which is part of the concern rather than a selling point.

Sellers often make dramatic weight-loss claims.

Our page on natural GLP-1 receptor agonists looks at foods and supplements said to influence the hormone. The honest framing is that diet quality matters for health, but nothing you can buy off a shelf replicates a prescribed receptor agonist's action. The same goes for vitamins; see what UK evidence shows on vitamins and weight loss.

Does Ozempic burn fat or just suppress appetite? Ozempic (semaglutide) acts on GLP-1 receptors that help regulate appetite and slow how quickly the stomach empties, rather than burning fat directly, but it is licensed for type 2 diabetes only and is not a UK weight-loss medicine. Ask your prescriber about protein, activity and strength work alongside treatment.

Can you smell when someone is on Ozempic? A smell is not a listed side effect in the UK patient leaflet. If you notice any new symptom, discuss it with your prescriber and report it through the Yellow Card scheme.¹⁹

If cost is what draws you to alternatives, compare like with like. Across the UK pharmacies we track, Mounjaro pens range from £143.96 to £339.00 per month depending on dose and provider, checked 10 October 2026. Our own prices are shown live, and the consultation is free.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹